Brief: InspireMD Announces Approval Of Application For Pivotal Study Of The CGuard Prime 80Cm Carotid Stent System
07/10/2024 12:03
Oct 7 (Reuters) - InspireMD Inc NSPR.O :
* INSPIREMD ANNOUNCES APPROVAL OF INVESTIGATIONAL DEVICE
EXEMPTION
(IDE) APPLICATION FOR CGUARDIANS II PIVOTAL STUDY OF THE CGUARD
PRIME 80CM CAROTID STENT SYSTEM
Source text for Eikon: ID:nGNX5dtfdD
Further company coverage: NSPR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on InspireMD
See all newsInspireMD Inc reports results for the quarter ended June 30 - Earnings Summary
InspireMD Q2 revenue beats estimates on international demand
InspireMD Inc expected to post a loss of 20 cents a share - Earnings Preview
InspireMD Inc expected to post a loss of 20 cents a share - Earnings Preview
InspireMD Q1 revenue jumps 122%, beats estimates on product demand